These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18648396)

  • 1. Characterization of a 7.6-Mb germline deletion encompassing the NF1 locus and about a hundred genes in an NF1 contiguous gene syndrome patient.
    Pasmant E; de Saint-Trivier A; Laurendeau I; Dieux-Coeslier A; Parfait B; Vidaud M; Vidaud D; Bièche I
    Eur J Hum Genet; 2008 Dec; 16(12):1459-66. PubMed ID: 18648396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mosaicism of a greater than 1.7-Mb deletion of genomic DNA involving the entire NF1 gene as verified by FISH: further evidence for a contiguous gene syndrome in 17q11.2.
    Streubel B; Latta E; Kehrer-Sawatzki H; Hoffmann GF; Fonatsch C; Rehder H
    Am J Med Genet; 1999 Nov; 87(1):12-6. PubMed ID: 10528240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncommon Alu-mediated NF1 microdeletion with a breakpoint inside the NF1 gene.
    Gervasini C; Venturin M; Orzan F; Friso A; Clementi M; Tenconi R; Larizza L; Riva P
    Genomics; 2005 Feb; 85(2):273-9. PubMed ID: 15676286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular studies in 20 submicroscopic neurofibromatosis type 1 gene deletions.
    Lopez Correa C; Brems H; Lázaro C; Estivill X; Clementi M; Mason S; Rutkowski JL; Marynen P; Legius E
    Hum Mutat; 1999; 14(5):387-93. PubMed ID: 10533064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic organization and evolution of the NF1 microdeletion region.
    De Raedt T; Brems H; Lopez-Correa C; Vermeesch JR; Marynen P; Legius E
    Genomics; 2004 Aug; 84(2):346-60. PubMed ID: 15233998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The heterogeneous nature of germline mutations in NF1 patients with malignant peripheral serve sheath tumours (MPNSTs).
    Upadhyaya M; Spurlock G; Majounie E; Griffiths S; Forrester N; Baser M; Huson SM; Gareth Evans D; Ferner R
    Hum Mutat; 2006 Jul; 27(7):716. PubMed ID: 16786508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of four novel large deletions in the human neurofibromatosis type 1 (NF1) gene.
    Fang LJ; Vidaud D; Vidaud M; Thirion JP
    Hum Mutat; 2001 Dec; 18(6):549-50. PubMed ID: 11748857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline mutations in NF1 patients with malignancies.
    Wu R; López-Correa C; Rutkowski JL; Baumbach LL; Glover TW; Legius E
    Genes Chromosomes Cancer; 1999 Dec; 26(4):376-80. PubMed ID: 10534774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis type 1 (NF1): Identification of eight unreported mutations in NF1 gene in Italian patients [corrected].
    Origone P; Bellini C; Sambarino D; Banelli B; Morcaldi G; La Rosa C; Stanzial F; Castellan C; Coviello DA; Garrè C; Bonioli E
    Hum Mutat; 2003 Aug; 22(2):179-80. PubMed ID: 12872266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
    Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
    J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 17q inversion involving the neurofibromatosis type one locus in a family with neurofibromatosis type one.
    Asamoah A; North K; Doran S; Wagstaff J; Ogle R; Collins FS; Korf BR
    Am J Med Genet; 1995 Aug; 60(4):312-6. PubMed ID: 7485267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A large deletion (1.5 Mb) encompassing the neurofibromatosis type 1 (NF1) gene in a patient with sporadic NF1 associated with dysmorphism, mental retardation, and unusual ocular and skeletal features.
    Oktenli C; Saglam M; Demirbas S; Thompson P; Upadhyaya M; Consoli C; Ulucan H; Koz C; Durukan AH; Bozkurt A; Koc B; Kocar IH; Gul D
    Clin Dysmorphol; 2003 Jul; 12(3):199-201. PubMed ID: 14564162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Example of somatic mosaicism in a series of de novo neurofibromatosis type 1 cases due to a maternally derived deletion.
    Ainsworth PJ; Chakraborty PK; Weksberg R
    Hum Mutat; 1997; 9(5):452-7. PubMed ID: 9143926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
    Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
    Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three different pathological lesions in the NF1 gene originating de novo in a family with neurofibromatosis type 1.
    Upadhyaya M; Majounie E; Thompson P; Han S; Consoli C; Krawczak M; Cordeiro I; Cooper DN
    Hum Genet; 2003 Jan; 112(1):12-7. PubMed ID: 12483293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel recurrent nonsense mutation causing neurofibromatosis type 1 (NF1) in a family segregating both NF1 and Noonan syndrome.
    Bahuau M; Houdayer C; Assouline B; Blanchet-Bardon C; Le Merrer M; Lyonnet S; Giraud S; Récan D; Lakhdar H; Vidaud M; Vidaud D
    Am J Med Genet; 1998 Jan; 75(3):265-72. PubMed ID: 9475595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of copy number changes at the NF1 locus with improved high-resolution array CGH.
    Shen MH; Mantripragada K; Dumanski JP; Frayling I; Upadhyaya M
    Clin Genet; 2007 Sep; 72(3):238-44. PubMed ID: 17718862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete physical map and gene content of the human NF1 tumor suppressor region in human and mouse.
    Jenne DE; Tinschert S; Dorschner MO; Hameister H; Stephens K; Kehrer-Sawatzki H
    Genes Chromosomes Cancer; 2003 Jun; 37(2):111-20. PubMed ID: 12696059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a cytogenetic 17q11.2 deletion in an NF1 patient with a contiguous gene syndrome.
    Riva P; Castorina P; Manoukian S; Dalprà L; Doneda L; Marini G; den Dunnen J; Larizza L
    Hum Genet; 1996 Dec; 98(6):646-50. PubMed ID: 8931693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.